US drug prices remain high despite Medicare negotiations
Despite recent Medicare negotiations that reduced prices for 10 key drugs, Americans still pay significantly more than their counterparts in other developed nations.
An analysis shows that, effective January 2026, the new US prices for these medications are over double those in countries like Australia, Canada, and Sweden.
American citizens are also paying thousands more than Sweden and other nations for costly treatments like Imbruvica and Stelara.
While Medicare’s negotiations brought relief, experts say the US continues to overpay dramatically.
They are emphasizing the need for more robust price control measures to align closer with global standards.
Have Your Say!
Have you been affected by the issues raised in this story? Please share your experiences by emailing haveyoursay@soundvision.com.
Please include a contact number if you are willing to speak to a Muslim Network TV’s representative. You can also get in touch in the following ways:
Tweet: @MuslimNetworkTV
We must take charge of our narrative. Research indicates that 92% of their Muslim coverage is negative. Help us change that.
